ClinicalTrials.govpublic full text
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
locally advanced or metastatic solid tumors, asp388b, safety, tolerability, pembrolizumab, carboplatin, 5-fluorouracil (5-fu), oxaliplatin, head and neck squamous cell carcinoma (hnscc), esophageal squamous cell carcinoma (escc), metastatic castration-resistant prostate cancer(mcrpc), squamous non-small cell lung cancer (sqnsclc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 806826
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.